학술논문

Vitiligo Treated with Combined Piperine-Based Topical Treatment and Narrowband Ultraviolet B Therapy: Follow-Up with Reflectance Confocal Microscopy.
Document Type
Academic Journal
Author
Bertoli C; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.; Chester J; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.; Cortelazzi C; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.; Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.; Ciardo S; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.; Manfredini M; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.; Di Nuzzo S; Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.; Kaleci S; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.; Pellacani G; Dermatology Clinic, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00196 Rome, Italy.; Farnetani F; Department of Dermatology, University of Modena and Reggio Emilia, 41123 Modena, Italy.
Source
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2075-4418
Abstract
Background: Reflectance confocal microscopy (RCM) has a defined in vivo morphology of vitiligo and re-pigmentation. Combination therapies seem more effective than monotherapies.
Objective: We aim to describe the clinical and RCM features of re-pigmentation with combined narrowband ultraviolet B (NB-UVB) and piperine-based topical treatment in localized vitiligo.
Methods: Eight patients enrolled at a single center received combined treatment: topical treatment was applied twice daily + NB-UVB twice weekly for 2 × 2-month periods. Clinical changes were analyzed by the Vitiligo Noticeability Scale (VNS) and percentage of re-pigmentation. The evaluator agreement was assessed. Predefined RCM features had the presence/absence of (i) blood vessels, (ii) dendritic cells, and the quantity of (i) an irregular honeycombed pattern and (ii) non-pigmented papillae. Clinical and RCM monitoring was performed at the baseline, 2, 3, 5, and 7 months.
Results: Macules were "slightly less noticeable" with 25-50% re-pigmentation. Irregular honeycomb patterns and non-pigmented papillae were significantly less frequently observed, and in less extended areas (T1 vs. T2, p = 0.039; T0 vs. T1, p = 0.005 and T2 vs. T4, p = 0.033). Dendritic cells and blood vessels improved, with significant changes in blood vessels (T1 vs. T2, p = 0.005 and T3 vs. T4, p = 0.008).
Conclusions: RCM confirms the morphological changes induced by combined treatment for localized vitiligo.